Upside Purchased on Auxilium Pharma (AUXL)
Shares of Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) are higher on the session by 1.97%, currently trading at $26.37. The stock has been moving largely lower over the past six months, though has based out and regained the 50-day moving average as of late.
Options traders are buying some upside on the name today as well. The September $30.00 call was purchased 1,100 times, on the offer, a short while ago; open interest on the strike is 176 contracts. This signals new positioning on the strike.
Call volume is now running at 4.74x the daily average.
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on the hand, and rheumatologists. The company markets two products in the United States.
For more great research like this, as well as how to play it through options…please visit Benzinga’s Options & Volatility Edge and Benzinga’s Cash Generator.
Get trading ideas that can bring you a 100% return.
